▶ 調査レポート

ヒト血小板溶解物(HPL)の世界市場

• 英文タイトル:Global Market Study on Human Platelet Lysate: Europe to Remain Second Most Lucrative Regional Market Through 2026

Persistence Market Researchが調査・発行した産業分析レポートです。ヒト血小板溶解物(HPL)の世界市場 / Global Market Study on Human Platelet Lysate: Europe to Remain Second Most Lucrative Regional Market Through 2026 / B-PMR-AG010資料のイメージです。• レポートコード:B-PMR-AG010
• 出版社/出版日:Persistence Market Research / 2018年7月3日
• レポート形態:英文、PDF、214ページ
• 納品方法:Eメール(受注後2営業日)
• 産業分類:Life Sciences & Transformational Health
• 販売価格(消費税別)
  Individual(1名、印刷不可)¥524,300 (USD4,900)▷ お問い合わせ
  Multi User(5名)¥813,200 (USD7,600)▷ お問い合わせ
  Corporate User¥1,134,200 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、ヒト血小板溶解物(HPL)の世界市場について調べ、ヒト血小板溶解物(HPL)の世界規模、市場動向、市場環境、製品種類別分析、用途別分析、需要先別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。
・エグゼクティブサマリー
・調査手法
・ヒト血小板溶解物(HPL)の世界市場環境
・ヒト血小板溶解物(HPL)の世界市場動向
・ヒト血小板溶解物(HPL)の世界市場規模
・ヒト血小板溶解物(HPL)の世界市場規模:製品種類別
・ヒト血小板溶解物(HPL)の世界市場規模:用途別
・ヒト血小板溶解物(HPL)の世界市場規模:需要先別
・ヒト血小板溶解物(HPL)の世界市場:地域別市場規模・分析
・ヒト血小板溶解物(HPL)の北米市場規模・予測
・ヒト血小板溶解物(HPL)のアメリカ市場規模・予測
・ヒト血小板溶解物(HPL)のヨーロッパ市場規模・予測
・ヒト血小板溶解物(HPL)のアジア市場規模・予測
・ヒト血小板溶解物(HPL)の日本市場規模・予測
・ヒト血小板溶解物(HPL)の中国市場規模・予測
・ヒト血小板溶解物(HPL)のインド市場規模・予測
・関連企業情報・競争状況

This Persistence Market Research (PMR) report examines the global human platelet lysate market for the period 2018–2026. The primary objective of the report is to offer insights into market opportunity for human platelet lysate and pipeline developments in human platelet lysate market.

The global human platelet lysate market has seen promising growth in the last decade in the global market, as human platelet lysate has emerged as a boom for cell manufacturing for cell-based therapeutics. Funding for Life Science research and investments in this area serves to expand various projects undertaken and personnel employed. Sources of R&D spending include governments, private funding or commercial organizations. Academic research institutes have focused on advanced basic research, including applied research when government or industrial organizations prefer cost-effective ways to pursue development programs. A majority of basic research continues to be carried out at academia as companies focus on bringing products to the market with an eye towards generating profits. The continuous increase in research centres as government is providing funds/grants and increased demand for new products with lower price represent additional opportunities for the manufacturers of human platelet lysate.

The global human platelet lysate market has been segmented based on:

Product Type
Application
End User
Region
The report analyzes the global human platelet lysate market in terms of value (US$ Mn). The report begins with the market definition and explaining different products types and products used to conduct research and development activities. The market view point section includes PMR’s analysis on key trends, drivers, opportunities, trends and macro factors influencing the global market. Opportunity analysis provided in the section allows the client to better equip with crystal clear decision-making insights. Overview on human platelet lysate for clinical use would provide future prospects of the market. Pipeline analysis provided in the subsequent section helps the client to identify future rivals in the global market.

The report analyzes the market based on regions and presents the forecast in terms of value for the next 8 years. Regions covered in the report include:

North America
Latin America
Europe
Asia Pacific (APAC)
Middle East and Africa (MEA)
Each of these sections analyze regional market by product type, application, end user and country. Regional introductory section provides current scenario of life science and cell therapy provisions in representative countries, clinical and research use, research & development related resources such as number of academic & research institutes, cell therapy service providers, biotechnology companies, market access pathways for new human platelet lysate and current human platelet donation and processing pattern adopted by guidelines. Representative market participants section gives the list of companies operating in every region, competitive landscape and intensity map of their presence in each region.

To arrive at the market size, we have used our in-house data-based model to estimate human platelet lysate market size. We have adopt bottom-up approach to forecast the human platelet lysate market globally. Weighted average selling price is considered to estimate the market size of various products mentioned in the scope of the study. The country price is captured with the local currency. The local currency figures is then converted to USD to offer forecasts in a consistent currency standard. Furthermore, PMR has also considered the latest annual exchange rate to reflect the impact of the most recent economic conditions of country. Prices considered in the models are standardized based on the average packaging and types of product.

The forecast presented in the report provides total revenue of currently approved human platelet lysate products over 2018–2026. In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global market.

In the next section of the report, the ‘Competitive Landscape’ is included to provide report audiences with a dashboard view and to access the key differentiators among the competitor firms. Market structure analysis provides tier-wise breakdown of total market revenue. The section also provides company share analysis and market structure analysis for key market players. The market structure analysis would enable the client to identify their position in the market in comparison to their global peers. This section is primarily designed to provide the client with an objective and detailed comparative assessment of product offerings and strategies of key providers specific to a market segments. Detailed profiles of players in the human platelet lysate market are also provided in the report, which highlights company description, overview, product/segment overview, SWOT analysis, financial information, key developments related to market and strategic overview.

The next section of the report analyzes the market based on product and presents the forecast in terms of value for the next 8 years. The human platelet lysate types covered in the report include:

Heparin-free Platelet Lysate
Platelet Lysate with Heparin
The next section of report analyzes the market based on application for human platelet lysate products and provides forecast in terms of value for the next 8 years. The application segments covered in this report includes:

Research Use
Clinical Use
The next section of report analyzes the market based on end user for human platelet lysate products and provides forecast in terms of value for the next 8 years. The end-use segments covered in this report include:

Academic & Research Institutes
Biopharmaceutical Companies
Others (Contract Research Organizations and Cell Therapy Manufacturers)
Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective of the products. To understand key growth segments, Persistence Market Research provides the ‘Attractiveness Index’ analysis which helps the client to identify real market opportunities.

レポート目次

1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. PMR Analysis and Recommendations
1.4. Wheel of Fortune

2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy

3. Human Platelet Lysate Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis

4. Market Background
4.1. Market Dynamics
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Trends
4.2. Product Life Cycle
4.3. Application Scenario

5. Global Economic Outlook
5.1. Gross Domestic Product by Region & Country, 2006 – 2021
5.2. Global Healthcare Market Outlook

6. North America Human Platelet Lysate Market Analysis 2013–2017 and Forecast 2018–2026
6.1. Introduction
6.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2017
6.2.1. U.S.
6.2.2. Canada
6.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
6.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
6.4.1. Heparin-free Platelet Lysate
6.4.2. Platelet Lysate with Heparin
6.5. Market Size (US$ Mn) and Forecast By Product Type, 2018–2026
6.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
6.6.1. Research Use
6.6.2. Clinical Use
6.7. Market Size (US$ Mn) Forecast By Application, 2018–2026
6.8. Historical Market Size (US$ Mn) Analysis By End User, 2013–2017
6.8.1. Academic & Research Institutes
6.8.2. Biopharmaceutical Companies
6.8.3. Others
6.9. Market Size (US$ Mn) Forecast By End User, 2018–2026
6.10. Market Attractiveness Analysis
6.10.1. By Country
6.10.2. By Product Type
6.10.3. By Application
6.10.4. By End User
6.11. Drivers and Restraints – Impact Analysis

7. Latin America Human Platelet Lysate Market Analysis 2013–2017 and Forecast 2018–2026
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Trends Analysis By Country, 2012–2016
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Rest of Latin America
7.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
7.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
7.4.1. Heparin-free Platelet Lysate
7.4.2. Platelet Lysate with Heparin
7.5. Market Size (US$ Mn) and Forecast By Product Type, 2018–2026
7.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
7.6.1. Research Use
7.6.2. Clinical Use
7.7. Market Size (US$ Mn) Forecast By Application, 2018–2026
7.8. Historical Market Size (US$ Mn) Analysis By End User, 2013–2017
7.8.1. Academic & Research Institutes
7.8.2. Biopharmaceutical Companies
7.8.3. Others
7.9. Market Size (US$ Mn) Forecast By End User, 2018–2026
7.10. Market Attractiveness Analysis
7.10.1. By Country
7.10.2. By Product Type
7.10.3. By Application
7.10.4. By End User
7.11. Drivers and Restraints – Impact Analysis

8. Europe Human Platelet Lysate Market Analysis 2013–2017 and Forecast 2018–2026
8.1. Introduction
8.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
8.2.1. Germany
8.2.2. U.K.
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe
8.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
8.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
8.4.1. Heparin-free Platelet Lysate
8.4.2. Platelet Lysate with Heparin
8.5. Market Size (US$ Mn) and Forecast By Product Type, 2018–2026
8.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
8.6.1. Research Use
8.6.2. Clinical Use
8.7. Market Size (US$ Mn) Forecast By Application, 2018–2026
8.8. Historical Market Size (US$ Mn) Analysis By End User, 2013–2017
8.8.1. Academic & Research Institutes
8.8.2. Biopharmaceutical Companies
8.8.3. Others
8.9. Market Size (US$ Mn) Forecast By End User, 2018–2026
8.10. Market Attractiveness Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.10.4. By End User
8.11. Drivers and Restraints – Impact Analysis

9. Asia Pacific Human Platelet Lysate Market Analysis 2013–2017 and Forecast 2018–2026
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
9.2.1. China
9.2.2. Japan
9.2.3. India
9.2.4. ASEAN
9.2.5. Australia and New Zealand
9.2.6. Rest of Asia Pacific
9.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
9.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
9.4.1. Heparin-free Platelet Lysate
9.4.2. Platelet Lysate with Heparin
9.5. Market Size (US$ Mn) and Forecast By Product Type, 2018–2026
9.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
9.6.1. Research Use
9.6.2. Clinical Use
9.7. Market Size (US$ Mn) Forecast By Application, 2018–2026
9.8. Historical Market Size (US$ Mn) Analysis By End User, 2013–2017
9.8.1. Academic & Research Institutes
9.8.2. Biopharmaceutical Companies
9.8.3. Others
9.9. Market Size (US$ Mn) Forecast By End User, 2018–2026
9.10. Market Attractiveness Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By End User
9.11. Drivers and Restraints – Impact Analysis

10. Middle East & Africa Human Platelet Lysate Market Analysis 2013–2017 and Forecast 2018–2026
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
10.2.1. GCC Countries
10.2.2. South Africa
10.2.3. North Africa
10.2.4. Rest of MEA
10.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
10.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
10.4.1. Heparin-free Platelet Lysate
10.4.2. Platelet Lysate with Heparin
10.5. Market Size (US$ Mn) and Forecast By Product Type, 2018–2026
10.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
10.6.1. Research Use
10.6.2. Clinical Use
10.7. Market Size (US$ Mn) Forecast By Application, 2018–2026
10.8. Historical Market Size (US$ Mn) Analysis By End User, 2013–2017
10.8.1. Academic & Research Institutes
10.8.2. Biopharmaceutical Companies
10.8.3. Others
10.9. Market Size (US$ Mn) Forecast By End User, 2018–2026
10.10. Market Attractiveness Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By End User
10.11. Drivers and Restraints – Impact Analysis

11. Forecast Factors: Relevance and Impact

12. Market Structure Analysis
12.1. Market Structure Analysis by Tier
12.2. Company Share Analysis (2017)

13. Competition Analysis
13.1. Competition Dashboard
13.2. Competition Benchmarking
13.3. Company Deep Dive
13.3.1. Merck KGaA
13.3.1.1. Overview
13.3.1.2. Product and Application Portfolio
13.3.1.3. Production Footprint
13.3.1.4. Sales Footprint
13.3.1.5. Channel Footprint
13.3.1.6. Strategy
13.3.2. Compass Biomedical Inc.
13.3.2.1. Overview
13.3.2.2. Product and Application Portfolio
13.3.2.3. Production Footprint
13.3.2.4. Sales Footprint
13.3.2.5. Channel Footprint
13.3.2.6. Strategy
13.3.3. Macopharma SA
13.3.3.1. Overview
13.3.3.2. Product and Application Portfolio
13.3.3.3. Production Footprint
13.3.3.4. Sales Footprint
13.3.3.5. Channel Footprint
13.3.3.6. Strategy
13.3.4. Cook Medical (Cook Regentec)
13.3.4.1. Overview
13.3.4.2. Product and Application Portfolio
13.3.4.3. Production Footprint
13.3.4.4. Sales Footprint
13.3.4.5. Channel Footprint
13.3.4.6. Strategy
13.3.5. Mill Creek Life Sciences Llc.
13.3.5.1. Overview
13.3.5.2. Product and Application Portfolio
13.3.5.3. Production Footprint
13.3.5.4. Sales Footprint
13.3.5.5. Channel Footprint
13.3.5.6. Strategy
13.3.6. Stemcell Technologies Inc.
13.3.6.1. Overview
13.3.6.2. Product and Application Portfolio
13.3.6.3. Production Footprint
13.3.6.4. Sales Footprint
13.3.6.5. Channel Footprint
13.3.6.6. Strategy
13.3.7. Zen-Bio, Inc.
13.3.7.1. Overview
13.3.7.2. Product and Application Portfolio
13.3.7.3. Production Footprint
13.3.7.4. Sales Footprint
13.3.7.5. Channel Footprint
13.3.7.6. Strategy
13.3.8. Sclavo Diagnostics International Srl.
13.3.8.1. Overview
13.3.8.2. Product and Application Portfolio
13.3.8.3. Production Footprint
13.3.8.4. Sales Footprint
13.3.8.5. Channel Footprint
13.3.8.6. Strategy
13.3.9. Life Science Group Limited
13.3.9.1. Overview
13.3.9.2. Product and Application Portfolio
13.3.9.3. Production Footprint
13.3.9.4. Sales Footprint
13.3.9.5. Channel Footprint
13.3.9.6. Strategy
13.3.10. Trinova Biochem Gmbh
13.3.10.1. Overview
13.3.10.2. Product and Application Portfolio
13.3.10.3. Production Footprint
13.3.10.4. Sales Footprint
13.3.10.5. Channel Footprint
13.3.10.6. Strategy

14. Global Human Platelet Lysate Market Analysis 2013–2017 and Forecast 2018–2026, By Region
14.1. Introduction/Key Findings
14.2. Historical Market Size (US$ Mn) Analysis By Region, 2013–2017
14.3. Market Size (US$ Mn) Forecast By Region, 2018–2026
14.3.1. North America
14.3.2. Latin America
14.3.3. Europe
14.3.4. Asia Pacific excluding China
14.3.5. Middle East & Africa
14.4. Market Attractiveness Analysis By Region

15. Global Human Platelet Lysate Analysis 2013–2017 and Forecast 2018–2026, By Product Type
15.1. Introduction/Key Findings
15.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013–2017
15.2.1. Heparin-free Platelet Lysate
15.2.2. Platelet Lysate with Heparin
15.3. Market Size (US$ Mn) and Forecast By Product Type, 2018–2026
15.4. Market Attractiveness Analysis By Product Type

16. Global Human Platelet Lysate Market Analysis 2013–2017 and Forecast 2018–2026, By Application
16.1. Introduction/Key Findings
16.2. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
16.2.1. Research Use
16.2.2. Clinical Use
16.3. Market Size (US$ Mn) Forecast By Application, 2018–2026
16.4. Market Attractiveness Analysis By Application

17. Global Human Platelet Lysate Market Analysis 2013–2017 and Forecast 2018–2026, By End User
17.1. Introduction/Key Findings
17.2. Historical Market Size (US$ Mn) Analysis By End User, 2013–2017
17.2.1. Academic & Research Institutes
17.2.2. Biopharmaceutical Companies
17.2.3. Others
17.3. Market Size (US$ Mn) Forecast By End User, 2018–2026
17.4. Market Attractiveness Analysis By End User

18. Global Human Platelet Lysate Market Analysis 2013–2017 and Forecast 2018–2026
18.1. Y-o-Y Growth Analysis
18.2. Absolute $ Opportunity

List of Tables

Table 01: Human Platelet Lysate Market: Application Scenario
Table 02: Human Platelet Lysate Market: Application Scenario
Table 03: North America Human Platelet Lysate Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Country
Table 04: North America Human Platelet Lysate Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Product
Table 05: North America Human Platelet Lysate Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Application
Table 06: North America Human Platelet Lysate Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By End User
Table 07: Latin America Human Platelet Lysate Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Country
Table 08: Latin America Human Platelet Lysate Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Product
Table 09: Latin America Human Platelet Lysate Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Application
Table 10: Latin America Human Platelet Lysate Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By End User
Table 11: Europe Human Platelet Lysate Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Country
Table 12: Europe Human Platelet Lysate Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Product
Table 13: Europe Human Platelet Lysate Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Application
Table 14: Europe Human Platelet Lysate Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By End User
Table 15: Asia Pacific Human Platelet Lysate Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Country
Table 16: Asia Pacific Human Platelet Lysate Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Product
Table 17: Asia Pacific Human Platelet Lysate Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Application
Table 18: Asia Pacific Human Platelet Lysate Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By End User
Table 19: Middle East & Africa Human Platelet Lysate Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Country
Table 20: Middle East & Africa Human Platelet Lysate Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Product
Table 21: Middle East & Africa Human Platelet Lysate Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Application
Table 22: Middle East & Africa Human Platelet Lysate Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By End User
Table 23: Global Human Platelet Lysate Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Region
Table 24: Global Human Platelet Lysate Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Product Type
Table 25: Global Human Platelet Lysate Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Application
Table 26: Global Human Platelet Lysate Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By End User